Tang, Monica http://orcid.org/0000-0003-0075-2176
Schaffer, Andrea
Kiely, Belinda E.
Daniels, Benjamin
Simes, Robert J.
Lee, Chee K.
Pearson, Sallie-Anne
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1151479, 1158763, 1060407)
National Breast Cancer Foundation (DS-18-01)
Translational Cancer Research Network Clinical, supported by the Cancer Institute NSW
Cooperative Research Centres, Australian Government Department of Industry (CRC-P-439)
Article History
Received: 7 June 2019
Revised: 7 October 2019
Accepted: 9 October 2019
First Online: 1 November 2019
Change Date: 29 May 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-020-0908-5
Competing interests
: M.T. reports travel support from Roche, outside the submitted work. B.E.K. reports funding from Roche and TEVA for participating in advisory boards; speakers fees from Roche and Novartis; travel/conference expenses from Roche. S.A.P. is a member of the Drug Utilisation Sub Committee of the Pharmaceutical Benefits Advisory Committee. The views expressed in this paper do not represent those of the committee. The remaining authors declare no competing interests.
: This study was approved by the New South Wales Population and Health Services Research Ethics Committee (Approval Number: 2010/02/213). The Ethics Committee granted a waiver of the usual requirement for the consent of the individual to the use of their health information in a research project, in line with the guidelines approved under Section 95/95A of the Privacy Act 1988. The study was performed in accordance with the Declaration of Helsinki.
: This research is supported by the National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Medicines and Ageing (ID: 1060407) and a Cooperative Research Centre Project (CRC-P) Grant from the Australian Government Department of Industry, Innovation and Science (ID: CRC-P-439). M.T. is supported by a NHMRC Postgraduate Research Scholarship (ID: 1151479), a National Breast Cancer Foundation Postgraduate Scholarship Top-Up (ID: DS-18-01), and a Translational Cancer Research Network Clinical PhD Scholarship Top-Up award, supported by the Cancer Institute NSW. A.S. is supported by a NHMRC Early Career Fellowship (ID: 1158763).
: Not applicable.
: We thank the Australian Government Department of Human Services for providing the data. Data access was granted by the Australian Government Department of Human Services External Request Evaluation Committee (Approval Numbers: MI1474, MI1475, MI1477 and MI5858). Access to the datasets analysed during this study is not permitted without the express permission of the approving human research ethics committees and data custodians.